PharmaDispatch - BioPharmaDispatch

Latest News
CSL 'on track' to commence manufacture of AZ vaccine in November

The technology transfer process between AstraZeneca and CSL is well progressed with the Australian company on track to start manufacturing the COVID-19 adenovirus viral vector vaccine in November.

Latest News More calls for change from patient groups and companies October 21, 2020
More patient and company submissions to the parliamentary inquiry into approval processes for new medicines and medical technologies.
Latest News Services Australia reports significant jump in PBS benefits October 21, 2020
Services Australia processed 214 million PBS prescriptions in 2019-20 with total benefits of $13 billion, according to the organisation's annual report.
Latest News The COVID-19 vaccine manufacturing and supply deals October 21, 2020
The technology transfer process between AstraZeneca and CSL is well progressed, Mexico has announced agreements with three companies and Moderna's CEO said the company could seek an emergency authorisation of its mRNA vaccine in December.
Latest News ViiV Healthcare now looking to wider PBS listing October 21, 2020
ViiV Healthcare has welcomed a new TGA approval for HIV therapy DOVATO (dolutegravir and lamivudine) with the company now anticipating a wider PBS listing.
Comment Are negotiations an opportunity to reset on patient input? October 20, 2020
Have decision-making processes become so institutionalised they inadvertently exclude those this public health program is intended to serve.
Latest News 'A journey where we take the scenic route to get to our destination' October 20, 2020
Amicus Therapeutics has used its submission to the Zimmerman parliamentary inquiry to call for reform of funding processes for therapies that treat rare disease.
Latest News Growth in immunoglobulin slows but still key driver October 20, 2020
The Australian Red Cross Lifeblood and CSL Behring were the dominant providers to the National Blood Authority last year, according to the organisation's annual report.
Latest News Migraine Australia says community 'deflated… and very angry' October 19, 2020
"We do not use words like unfair, bias, compromised, or risk lightly: we use these words as an accurate indicator of what we have observed," says Migraine Australia in its submission to a parliamentary inquiry into medicine approval processes.
Latest News Pfizer CEO indicates efficacy readout could be just weeks away October 19, 2020
Pfizer CEO Albert Bourla has written another open letter on the company's work to develop a COVID-19 vaccine indicating it could seek emergency authorisation for its use in the second half of November.
Latest News STA cancer therapy progressing to late-stage COVID-19 trial October 19, 2020
Australian company Specialised Therapeutics Australia has updated on a trial of its cancer therapy APLIDIN (plitidepsin) as a potential treatment for COVID-19 infection.

News of the Day

Latest Video

Most Read

New Stories